BioInformatics Launches New Experts-on-Demand Qualitative Research Service

BioInformatics, part of Science and Medicine Group, today announced the launch of a new qualitative research solution: Experts-on-Demand. The service helps connect companies with a network of thousands of life science and medical experts for one-hour telephone consultations.

 “The pace of science, technology, and medicine is moving faster than ever, and we have built a qualitative offering to match the new speed of business today. Our Experts-on-Demand consultants are profiled and responsive to meet the increasing needs of our clients,” said Craig Overpeck, chief executive officer of Science and Medicine Group.

The experts are drawn from The Science Advisory Board®, an expert network formed in 1997. Tens of thousands of laboratory professionals representing basic and translational life science research, drug discovery, and clinical diagnostics routinely participate in BioInformatics’ quantitative and qualitative global market research projects. The proprietary global network encompasses more than 25 market segments and includes scientists and clinicians with profiled expertise in 80 different research and diagnostic techniques.

“Experts-on-Demand facilitates direct communication between those on the cutting edge of science and medicine with those companies who must support them with ever more innovative technologies,” said Overpeck.

More information on Experts-on-Demand can be found here.

BioInformatics, now part of Science and Medicine Group, is the premier research and advisory firm serving the life science, clinical diagnostics, and analytical instrument industries. By leveraging our expert network of more than 50,000 profiled life scientists, the company has supported more than 500 companies in creating insights that lead to better business decisions. Offerings include assessing the size and attractiveness of scientific markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Science and Medicine Group Named to 2019 Inc. 5000 List

“Being named to the Inc. 5000 list is a tremendous achievement and a testament to the hard work of our talented staff,” said Craig Overpeck, CEO of Science and Medicine Group. “Our growth reflects the accelerated pace at which our clients are pursuing the use of science and medicine together to make our world a better place. We are proud to help them bring new tests, technologies, and treatments to the market utilizing our insights and global audiences of scientists and clinicians.”

Not only have the companies on the 2019 Inc. 5000 (see list at been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists. The 2019 Inc. 5000 achieved an astounding three-year average growth of 454%, and a median rate of 157%. The Inc. 5000’s aggregate revenue was $237.7 billion in 2018, accounting for 1.2 million jobs over the past three years.

“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc. Editor-in-Chief James Ledbetter. “There’s no single course you can follow or investment you can take that will guarantee this kind of spectacular growth, but what they have in common is persistence and seizing opportunities.”

Science and Medicine Group is a leading business information and media firm serving the life science, analytical instrument, clinical diagnostic, diagnostic imaging, and dental industries. The company’s portfolio includes market intelligence brands BioInformatics, IMV Medical Information, Instrument Business Outlook, Kalorama Information, and Strategic Directions International and media brands,,, and Science and Medicine Group, ranked No. 23 among media companies in the Inc. 5000, helps clients create strategies and products to win markets and provides platforms to digitally engage their markets through a variety of innovative solutions.

Media contact:

Justin Dudash
Vice President, Marketing
Science and Medicine Group Inc.
671 North Glebe Rd Suite 1610
Arlington, VA 22203
[email protected]

Science and Medicine Group Releases Two New Products for AACC 2019

Science and Medicine Group launches two new products at the annual meeting of the American Association for Clinical Chemistry (AACC) to help manufacturers of diagnostic instruments connect with their customers at clinical laboratories. The company will be demonstrating its new healthcare vertical portal,, which adds to the growing number of media properties in the Science and Medicine Group portfolio. It will also debut a new clinical instrument database for IVD vendors from Kalorama.

The first is, a website designed to provide late-breaking news and information to professionals working in clinical laboratories. Laboratory medicine is a rapidly growing field that is experiencing a technology transformation as new tools are becoming available to clinicians, such as digital pathology, liquid biopsy, point-of-care testing, mass spectrometry, and next-generation sequencing, as well as improved laboratory information systems (LIS) and IT support software. In addition, specialized content areas, called Communities, enable members to stay on top of important industry segments.  Segments include in vitro diagnostics, pathology, microbiology, point-of-care testing, and genomics. Advertising and sponsorship opportunities are now available.  The website is available at and the media kit can be downloaded here:

The second product launched is the Kalorama Clinical Masterfile. The product is designed to help clinical diagnostic vendors find customers, verify the data their sales team is providing, and locate weak points in the competition. The Clinical Masterfile is the most comprehensive database of the installed base of clinical laboratory equipment in the U.S.  An ongoing survey of more than 5,300 facilities continuously updates data on more than 41,000 analyzers including manufacturer, model, number installed, year installed and department location. The information is continuously gathered by phone and online reporting system with pathologists and lab managers at US CLIA labs.  Every major modality is covered including chemistry, coagulation, hematology, immunoassay, integrated systems, microbiology, and molecular diagnostics. Key demographics such as address, population served, budget and points-of-contact are included. More information is available at:

“The release of these new products further enhance our ability to connect our diagnostic clients with their customers at clinical laboratories,” said Craig Overpeck, CEO of Science and Medicine Group. “We facilitate the exchange of valuable information between the buyers and sellers in this fast changing market to the mutual benefit of both.”

Representatives will be on site to discuss both products at booth 4326 at the American Association for Clinical Chemistry Meeting in Anaheim, CA, August 6th to August 8th, 2019.

About Science and Medicine Group
Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Our clients, including some of the top Fortune 500 companies in the world, use our business intelligence, market research and publications, and marketing platforms to grow their businesses globally.

Media Contact:

Jonathan West
Science and Medicine Group
671 North Glebe Rd Suite 1610
Arlington, VA 22203
[email protected]